Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now early-phase tilt

Alcohol Dependence: early-phase trial registry

8 of 44 indexed Alcohol Dependence trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #330 of 28,707 conditions by registered trial count.

44 US clinical trials · 8 currently recruiting · #330 of 28,707 conditions by registered trial count

Alcohol Dependence: 44 US clinical trials tracked, 8 recruiting.

Alcohol Dependence is the subject of 44 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), running 8 of these trials.

Enrollment posture brief

Registry condition alcohol-dependence

OPEN 8 | RECR 18% | LATE 6 | EARLY 22 | RANK #330 | SPON 8

Nearest open-share peer: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (18% recruiting · 22 trials)

Esophageal Adenocarcinoma61.4%Anorexia Nervosa54.5%Castration-Resistant Prostat38.6%Childhood Obesity31.8%Alcohol Dependence (this)18%
Open-enrollment share among volume-matched conditions near Alcohol Dependence

Alcohol Dependence lists 8 open slots (18% of 44 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Alcohol Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Alcohol Dependence is recruiting below its size-band peers.

    8 of 44 indexed trials (18.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Alcohol Dependence research.

    National Institute on Alcohol Abuse and Alcoholism (NIAAA) accounts for 8 of 44 trials (18.2%). 27 distinct sponsors appear on at least one study for this condition label.

  3. Typical Alcohol Dependence enrolment sits around 90 participants.

    Median target enrolment is 90 among the 44 trials that report a genuine target (sentinel values excluded). 25 of those (56.8%) plan for fewer than 100 participants.

  4. Alcohol Dependence research is mostly interventional.

    41 interventional and 3 observational studies make up this index (93.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 219Phase 33Phase 43

Open and recent trials

44 total, page 1 of 1

RECRUITING 7,500 participants

Substance Abuse Pre-Treatment Screening Study

The University of Texas Health Science Center, Houston

NCT00439049

RECRUITING 1,000 participants

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT02108080

RECRUITING NA 400 participants

Behavioral and Functional Task Development, Implementation, and Testing

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT02108054

RECRUITING NA 200 participants

Virtual Incentive Treatment for Alcohol

Washington State University

NCT06265506

RECRUITING NA 186 participants

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

Brainsway

NCT07216872

RECRUITING Phase 2 80 participants

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

University of Iowa

NCT06405607

RECRUITING 72 participants

The Impact of Heavy Alcohol Use on Saliva and Oral Health

National Institutes of Health Clinical Center (CC)

NCT06684483

RECRUITING NA 10 participants

Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study

Wake Forest University Health Sciences

NCT06770556

ACTIVE NOT RECRUITING NA 135 participants

Telehealth Treatment for Alcohol Use Disorder

Ria Health

NCT05747703

COMPLETED Phase 3 508 participants

Making Alcoholics Anonymous Easier

Alcohol Research Group

NCT01382316

COMPLETED Phase 2 406 participants

ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence

Alkermes

NCT00981617

COMPLETED Phase 4 358 participants

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Medical University of South Carolina

NCT00920829

COMPLETED Phase 2 198 participants

Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)

Yale University

NCT00000451

COMPLETED Phase 2 190 participants

A Study in the Treatment of Alcohol Dependence.

Eli Lilly and Company

NCT00805441

COMPLETED NA 162 participants

Intensive Intervention for Smokers - 6

University of California, San Francisco

NCT00217984

COMPLETED Phase 2 156 participants

A Therapeutic Workplace for Alcohol Dependence

Johns Hopkins University

NCT00183144

COMPLETED Phase 2 150 participants

Gabapentin Treatment of Alcohol Dependence

The Scripps Research Institute

NCT00391716

COMPLETED NA 150 participants

Facilitating Aftercare for Alcohol Detox Patients

State University of New York at Buffalo

NCT00513708

COMPLETED NA 120 participants

Adolescent Trauma Recovery and Stress Disorders Collaborative Care (ATRSCC) Model Program Trial

University of Washington

NCT00619255

COMPLETED NA 116 participants

Chronic Alcohol, Stress Inflammatory Response and Relapse Risk

Yale University

NCT02193204

COMPLETED Phase 4 106 participants

Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT00006204

COMPLETED Phase 2 103 participants

Mifepristone Treatment of Alcohol Use Disorder

The Scripps Research Institute

NCT02179749

COMPLETED Phase 3 96 participants

Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).

Yale University

NCT00744055

COMPLETED Phase 2 91 participants

The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)

University of Rochester

NCT00851669

COMPLETED Phase 2 90 participants

Aripiprazole and Topiramate on Free-Choice Alcohol Use

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT00884884

COMPLETED NA 89 participants

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

Northwell Health

NCT00665249

COMPLETED Phase 2 87 participants

Combined Treatment for Cocaine-Alcohol Dependence - 1

The University of Texas Health Science Center, Houston

NCT00218569

COMPLETED NA 81 participants

Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders

Medical University of South Carolina

NCT01338506

COMPLETED NA 70 participants

A Tailored Physical Activity Smartphone App for Patients With Alcohol Dependence

Butler Hospital

NCT02958280

COMPLETED Early Phase 1 70 participants

The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT00667771

COMPLETED Phase 2 66 participants

Effect of LY686017 on Alcohol Craving

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT00310427

COMPLETED Phase 2 65 participants

An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence

Medical University of South Carolina

NCT00667875

COMPLETED Phase 3 54 participants

Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence

University of Wisconsin, Madison

NCT01856712

COMPLETED Phase 2 44 participants

Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence

Medical University of South Carolina

NCT01055171

COMPLETED Phase 4 40 participants

Zonisamide vs. Placebo in the Treatment of Alcohol Dependence

UConn Health

NCT00595556

COMPLETED Phase 2 40 participants

Gabapentin for Abstinence Initiation in Alcohol Dependence

New York State Psychiatric Institute

NCT01141049

COMPLETED Phase 2 39 participants

Baclofen for Treating Anxiety and Alcoholism

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT01751386

COMPLETED NA 35 participants

Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use

University of California, Los Angeles

NCT02603471

COMPLETED Phase 1 31 participants

Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics

VA Office of Research and Development

NCT01657760

COMPLETED Phase 2 30 participants

Aripiprazole Effects on Alcohol Reactivity and Consumption

Medical University of South Carolina

NCT00183235

COMPLETED Phase 2 24 participants

Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence

Yale University

NCT01847469

COMPLETED Phase 2 22 participants

Oxytocin Treatment of Alcohol Dependence

University of North Carolina, Chapel Hill

NCT02251912

COMPLETED Phase 1 14 participants

A Novel Compound for Alcoholism Treatment

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT02039349

COMPLETED Phase 2 9 participants

Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence

Yale University

NCT00639288

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 19
Phase 3 3
Phase 4 3

Named interventions

Most-linked intervention names on Alcohol Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
12 trials
Naltrexone Drug
5 trials
LY686017 Drug
2 trials
Placebo Other
2 trials
Standardized behavioral therapy Behavioral
1 trials
Mifepristone 1200 mg daily Drug
1 trials
ALKS33 (RDC-0313) (10 mg) Drug
1 trials
ALKS33 (RDC-0313) (2.5 mg) Drug
1 trials

US sites by state

Facility locations filed on Alcohol Dependence trials. A trial with sites in several states counts in each.

California 10 trials
Maryland 8 trials
New York 6 trials
Connecticut 6 trials
South Carolina 5 trials
Washington 3 trials
Texas 3 trials
North Carolina 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Alcohol Dependence page

44 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alcohol Dependence condition card totals 44 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.